Hyperglycemia in Renal Transplantation

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
DiabetesEnd Stage Renal Disease
Interventions
DRUG

Insulin

Insulin will be given in a continuous low dose infusion. The infusion will be adjusted based on the patient's blood sugar with the goal of keeping the level between 100-140 mg/dL

DRUG

Insulin, Asp(B28)-

Insulin will be given through subcutaneous injection every few hours based on the patient's blood sugar level.

Trial Locations (1)

94123

University of California San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01643382 - Hyperglycemia in Renal Transplantation | Biotech Hunter | Biotech Hunter